{"created":"2021-03-01T06:14:17.707995+00:00","id":10175,"links":{},"metadata":{"_buckets":{"deposit":"79c6dbb5-6b14-4637-93f6-4ca8c9a1ec37"},"_deposit":{"id":"10175","owners":[],"pid":{"revision_id":0,"type":"depid","value":"10175"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00010175","sets":["453:456","471:537:538:958"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"New Chemotherapy for Multiple Myeloma (Progress in the Treatment of Hematologic Diseases)"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2011-02","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"64","bibliographicPageStart":"61","bibliographicVolumeNumber":"125","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"多発性骨髄腫 (MM) は予後不良な造血器腫瘍であり, 治癒に導く治療法は確立していない. しかし, 近年になり新規治療薬の開発が進み, MM患者の生命予後やQOLは改善しつつある. 注目される新規抗腫瘍剤としてのボルテゾミブ, サリドマイド, レナリドマイドについて解説する.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"70079","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Takizawa, Jun"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"瀧澤, 淳"}],"nameIdentifiers":[{"nameIdentifier":"70078","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-06"}],"displaytype":"detail","filename":"125(2)_61-64.pdf","filesize":[{"value":"615.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"125(2)_61-64.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/10175/files/125(2)_61-64.pdf"},"version_id":"85a0bdaa-b255-4fe2-ac2f-07629557cdc7"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"多発性骨髄腫","subitem_subject_scheme":"Other"},{"subitem_subject":"ボルテゾミブ","subitem_subject_scheme":"Other"},{"subitem_subject":"サリドマイド","subitem_subject_scheme":"Other"},{"subitem_subject":"レナリドマイド","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"2 骨髄腫の新しい治療(血液疾患の治療をめぐる進歩,第658回新潟医学会)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"2 骨髄腫の新しい治療(血液疾患の治療をめぐる進歩,第658回新潟医学会)"},{"subitem_title":"2 骨髄腫の新しい治療(血液疾患の治療をめぐる進歩,第658回新潟医学会)","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","958"],"pubdate":{"attribute_name":"公開日","attribute_value":"2014-07-28"},"publish_date":"2014-07-28","publish_status":"0","recid":"10175","relation_version_is_last":true,"title":["2 骨髄腫の新しい治療(血液疾患の治療をめぐる進歩,第658回新潟医学会)"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:43:58.159809+00:00"}